ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 055,01
-0,13%
Dow Jones
38 386,09
0,38%
DAX
18 059,01
-0,40%
Brent Oil
87,465
0,21%
Bitcoin
61 725,07
-3,31%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) Actualités

VRTX Vertex Pharmaceuticals Inc

396,20
0,00 (0,00%)
Avant marché
Dernière mise à jour : 12:25:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 396,20 12:25:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
396,20
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202417:43BWVertex Announces European Commission Approval for KALYDECO®..
23/4/202406:45PRNUSVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING..
18/4/202414:00BWVertex Announces Advancements of Suzetrigine (VX-548) in..
11/4/202413:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
10/4/202422:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
09/4/202422:05BWVertex to Announce First Quarter 2024 Financial Results on..
01/4/202417:00PRNCAVertex Announces New Drug Submission for Exagamglogene..
01/4/202414:00BWVertex Advances Inaxaplin (VX-147) into Phase 3 Portion of..
21/3/202413:00BWVertex Announces FDA Clearance of Investigational New Drug..
27/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202419:19EDGAR2Form 144 - Report of proposed sale of securities
26/2/202417:25EDGAR2Form 144 - Report of proposed sale of securities
26/2/202417:10EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:26EDGAR2Form 144 - Report of proposed sale of securities
23/2/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:10BWVertex Receives CHMP Positive Opinion for KALYDECO® for the..
21/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202417:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:52EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:16EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:50EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:43EDGAR2Form 144 - Report of proposed sale of securities
20/2/202422:05BWVertex to Participate in Upcoming Investor Conferences
20/2/202417:29EDGAR2Form 144 - Report of proposed sale of securities
20/2/202417:03EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:57EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:32EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:22EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:22EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés